• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

暴露于新冠病毒变异株的单核细胞衍生巨噬细胞的转录组图谱揭示了由德尔塔驱动的免疫逃逸。

Transcriptomic profiles of monocyte-derived macrophages exposed to SARS-CoV-2 VOCs reveal immune-evasion escape driven by delta.

作者信息

Gallo Alessia, Sammartino Josè Camilla, Vazzana Roberta, Giambruno Roberto, Carcione Claudia, Cuscino Nicola, Castelbuono Salvatore, Miceli Vitale, Bulati Matteo, Lilleri Daniele, Cassaniti Irene, Conaldi Pier Giulio, Baldanti Fausto

机构信息

Department of Research, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), Palermo, Italy.

Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, Università degli Studi di Pavia, Pavia, Italy.

出版信息

J Transl Med. 2025 Feb 4;23(1):151. doi: 10.1186/s12967-025-06158-2.

DOI:10.1186/s12967-025-06158-2
PMID:39905461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11796281/
Abstract

BACKGROUND

Since the breakout of COVID-19, the mutated forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have shown enhanced rates of transmission and adaptation to humans. The variants of concern (VOC), designated Alpha, Beta, Gamma, Delta, and Omicron emerged independent of one another, and in turn rapidly became dominant. The success of each VOC, as well as the virus fitness, were enabled by altered intrinsic functional properties and, reasonably, to virus antigenicity changes, conferring the ability to evade a primed immune response.

METHODS

We analysed the gene expression profiles of monocyte-derived macrophages (MDM) isolated from whole blood of healthy participants exposed to the 5 different SARS-CoV-2 VOC: D614G, Alpha (B.1.1.7), Gamma (P1), Delta (B.1.617.2), and Omicron BA.1 (B.1.1.529), and to the HCoV-OC43 strain, a coronavirus already present in the population before the SARS-CoV-2 pandemic. Whole transcriptome RNA-Seq, for both coding and non-coding RNAs, was then made.

RESULTS

After exposure to the 5 VOC of MDM, we initially assessed the presence of the viral SARS-CoV-2 transcripts to confirm viral entry. We then analysed the RNA-Seq data and observed a significant deregulation of both coding and non-coding RNAs. In particular, our RNA-Seq analysis showed a significant up-regulation of several genes involved in different immunological processes, such as PARP9/PARP14 axes, in macrophages exposed to D614G, Alpha, and Gamma variants. Surprisingly, our data showed that macrophages exposed to the Delta variant exhibited a transcriptional profile more similar to the naïve control group, while macrophages exposed to the Omicron variant showed intermediate differentially expressed genes (DEGs) between the two groups. By checking the canonical markers for M1/M2 differentiation states, we did not observe any expression in macrophages exposed to the Delta variant, suggesting an M0 status, comparable to the naïve control group. Finally, we observed a significant deregulation of 3 main types of non-coding RNAs (ncRNAs): long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and small nucleolar RNAs (snoRNAs), some of which are common to coronaviruses, and some specific to SARS-CoV-2.

CONCLUSION

The SARS-CoV-2-dependent alteration of the transcriptome of monocyte-derived macrophage (MDM)-infected cells can be linked to the chronological order of the variants' appearance in the human population. Our data suggest an evolution of VOC in modulating the host immune response, with a strong change in pace beginning with the advent of the Delta variant. MDMs exposed to Delta showed a failure in the activation of the adaptive immune response, and this correlates with the more severe symptoms developed by people affected with this SARS-CoV-2 variant.

摘要

背景

自新冠疫情爆发以来,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的变异形式表现出更高的传播率以及对人类的适应性。值得关注的变异株(VOC),即阿尔法、贝塔、伽马、德尔塔和奥密克戎,彼此独立出现,继而迅速成为主导毒株。每个VOC的成功以及病毒适应性,是由内在功能特性的改变以及合理地归因于病毒抗原性变化所促成的,从而具备了逃避预先形成的免疫反应的能力。

方法

我们分析了从接触5种不同SARS-CoV-2 VOC(D614G、阿尔法(B.1.1.7)、伽马(P1)、德尔塔(B.1.617.2)和奥密克戎BA.1(B.1.1.529))以及人冠状病毒OC43毒株(一种在SARS-CoV-2大流行之前就已在人群中存在的冠状病毒)的健康参与者全血中分离出的单核细胞衍生巨噬细胞(MDM)的基因表达谱。然后对编码RNA和非编码RNA进行了全转录组RNA测序。

结果

在MDM接触5种VOC后,我们首先评估了病毒SARS-CoV-2转录本的存在情况以确认病毒进入。然后我们分析了RNA测序数据,观察到编码RNA和非编码RNA均出现显著失调。特别是,我们的RNA测序分析显示,在接触D614G、阿尔法和伽马变异株的巨噬细胞中,几个参与不同免疫过程的基因,如PARP9/PARP14轴,出现显著上调。令人惊讶的是,我们的数据显示,接触德尔塔变异株的巨噬细胞表现出与未接触病毒的对照组更相似的转录谱,而接触奥密克戎变异株的巨噬细胞则表现出两组之间的中间差异表达基因(DEG)。通过检查M1/M2分化状态的典型标志物,我们在接触德尔塔变异株的巨噬细胞中未观察到任何表达,表明其处于M0状态,与未接触病毒的对照组相当。最后,我们观察到3种主要类型的非编码RNA(ncRNA)出现显著失调:长链非编码RNA(lncRNA)、微小RNA(miRNA)和小核仁RNA(snoRNA),其中一些是冠状病毒共有的,一些是SARS-CoV-2特有的。

结论

SARS-CoV-2依赖的单核细胞衍生巨噬细胞(MDM)感染细胞转录组的改变可能与变异株在人群中出现的时间顺序有关。我们的数据表明VOC在调节宿主免疫反应方面存在演变,从德尔塔变异株出现开始,变化速度明显加快。接触德尔塔变异株的MDM在适应性免疫反应激活方面出现失败,这与感染这种SARS-CoV-2变异株的人出现的更严重症状相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/b4d8550d34a5/12967_2025_6158_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/aa0345ea87fe/12967_2025_6158_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/fd4172be66da/12967_2025_6158_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/c11278d9378f/12967_2025_6158_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/d634d1f183c2/12967_2025_6158_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/d31ce4ca96c0/12967_2025_6158_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/f655c91c9572/12967_2025_6158_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/aadb6be8f789/12967_2025_6158_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/b4d8550d34a5/12967_2025_6158_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/aa0345ea87fe/12967_2025_6158_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/fd4172be66da/12967_2025_6158_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/c11278d9378f/12967_2025_6158_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/d634d1f183c2/12967_2025_6158_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/d31ce4ca96c0/12967_2025_6158_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/f655c91c9572/12967_2025_6158_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/aadb6be8f789/12967_2025_6158_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/11796281/b4d8550d34a5/12967_2025_6158_Fig8_HTML.jpg

相似文献

1
Transcriptomic profiles of monocyte-derived macrophages exposed to SARS-CoV-2 VOCs reveal immune-evasion escape driven by delta.暴露于新冠病毒变异株的单核细胞衍生巨噬细胞的转录组图谱揭示了由德尔塔驱动的免疫逃逸。
J Transl Med. 2025 Feb 4;23(1):151. doi: 10.1186/s12967-025-06158-2.
2
SARS-CoV-2 variant biology: immune escape, transmission and fitness.SARS-CoV-2 变体生物学:免疫逃逸、传播和适应性。
Nat Rev Microbiol. 2023 Mar;21(3):162-177. doi: 10.1038/s41579-022-00841-7. Epub 2023 Jan 18.
3
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?奥密克戎:为何最新的 SARS-CoV-2 变体如此令人担忧?
J Virol. 2022 Mar 23;96(6):e0207721. doi: 10.1128/jvi.02077-21.
4
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.假型 SARS-CoV-2 变异株奥密克戎的显著免疫逃逸。
Emerg Microbes Infect. 2022 Dec;11(1):1-5. doi: 10.1080/22221751.2021.2017757.
5
SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.携带奥密克戎 BA.1 刺突的 SARS-CoV-2 株在 C57BL/6 小鼠中复制。
Front Immunol. 2024 Apr 29;15:1383612. doi: 10.3389/fimmu.2024.1383612. eCollection 2024.
6
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.SARS-CoV-2 奥密克戎、贝塔和德尔塔 plus 变体共享的 N417 依赖性表位。
J Virol. 2022 Aug 10;96(15):e0055822. doi: 10.1128/jvi.00558-22. Epub 2022 Jul 13.
7
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.奥密克戎变异株 BA.1.1 在 SARS-CoV-2 感染的猫模型中比 B.1 D614G 和德尔塔变异株的致病性更低。
J Virol. 2022 Sep 14;96(17):e0096122. doi: 10.1128/jvi.00961-22. Epub 2022 Aug 24.
8
Macrophages and γδ T cells interplay during SARS-CoV-2 variants infection.巨噬细胞和 γδ T 细胞在 SARS-CoV-2 变异感染过程中的相互作用。
Front Immunol. 2022 Dec 19;13:1078741. doi: 10.3389/fimmu.2022.1078741. eCollection 2022.
9
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.关于关注的 SARS-CoV-2 奥密克戎变异株及其特殊突变特征的最新信息。
Microbiol Spectr. 2022 Apr 27;10(2):e0273221. doi: 10.1128/spectrum.02732-21. Epub 2022 Mar 30.
10
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity.SARS-CoV-2 变异株 Alpha、Delta、Omicron 中的内在 D614G 和 P681R/H 突变,以及 Spike 蛋白中具有 D614G 加关键特征性突变的病毒,改变了融合性和感染性。
Med Microbiol Immunol. 2023 Feb;212(1):103-122. doi: 10.1007/s00430-022-00760-7. Epub 2022 Dec 30.

引用本文的文献

1
Exposure of monocyte-derived macrophages to the UV-inactivated SARS-CoV-2 VOCs shows similar effects on the transcriptomic profile as active virus: a comparative analysis.将单核细胞衍生的巨噬细胞暴露于紫外线灭活的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株(VOCs),对转录组图谱产生的影响与活病毒相似:一项比较分析。
J Transl Med. 2025 Mar 14;23(1):332. doi: 10.1186/s12967-025-06264-1.

本文引用的文献

1
Host Cell Death and Modulation of Immune Response against Infection.宿主细胞死亡与 感染免疫应答的调节。
Int J Mol Sci. 2024 Jun 6;25(11):6255. doi: 10.3390/ijms25116255.
2
Analysis of transcriptomics data from COVID-19 patients: a pilot research.新冠肺炎患者转录组学数据分析:一项初步研究。
Folia Microbiol (Praha). 2024 Feb;69(1):155-164. doi: 10.1007/s12223-024-01130-x. Epub 2024 Jan 19.
3
Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets.非编码 RNA 在 SARS-CoV-2 感染中的表达:发病机制、临床意义和治疗靶点。
Signal Transduct Target Ther. 2023 Dec 6;8(1):441. doi: 10.1038/s41392-023-01669-0.
4
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome.揭示PUS7介导的假尿苷化在针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)RNA基因组的宿主蛋白相互作用中的作用。
Mol Ther Nucleic Acids. 2023 Oct 25;34:102052. doi: 10.1016/j.omtn.2023.102052. eCollection 2023 Dec 12.
5
Overreactive macrophages in SARS-CoV-2 infection: The effects of ACEI.严重急性呼吸综合征冠状病毒2型感染中反应过度的巨噬细胞:血管紧张素转换酶抑制剂的作用
Int Immunopharmacol. 2023 Nov;124(Pt A):110858. doi: 10.1016/j.intimp.2023.110858. Epub 2023 Sep 12.
6
The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中长链非编码RNA(lncRNAs)和微小RNA(miRNAs)的调控
Front Cell Dev Biol. 2023 Jul 27;11:1229393. doi: 10.3389/fcell.2023.1229393. eCollection 2023.
7
Differentially-regulated miRNAs in COVID-19: A systematic review.新冠病毒病中差异表达的微小RNA:一项系统综述
Rev Med Virol. 2023 Jul;33(4):e2449. doi: 10.1002/rmv.2449. Epub 2023 May 5.
8
SARS-CoV-2 variant biology: immune escape, transmission and fitness.SARS-CoV-2 变体生物学:免疫逃逸、传播和适应性。
Nat Rev Microbiol. 2023 Mar;21(3):162-177. doi: 10.1038/s41579-022-00841-7. Epub 2023 Jan 18.
9
SARS-CoV-2 N protein potentiates host NPM1-snoRNA translation machinery to enhance viral replication.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核蛋白增强宿主核仁磷酸蛋白1(NPM1)-小核仁RNA(snoRNA)翻译机制以增强病毒复制。
Signal Transduct Target Ther. 2022 Oct 8;7(1):356. doi: 10.1038/s41392-022-01210-9.
10
Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital.对意大利北部一家医院接种BNT162b2疫苗的未感染新冠病毒医护人员和新冠病毒检测呈阳性的医护人员针对14种新冠病毒变异株的中和抗体反应的评估。
Vaccines (Basel). 2022 Apr 29;10(5):703. doi: 10.3390/vaccines10050703.